

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glomerulus development (GO:0032835) | 7.34625480 |
| 2 | actin-myosin filament sliding (GO:0033275) | 7.16014206 |
| 3 | muscle filament sliding (GO:0030049) | 7.16014206 |
| 4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.39255375 |
| 5 | actin-mediated cell contraction (GO:0070252) | 5.92850053 |
| 6 | myofibril assembly (GO:0030239) | 5.37202975 |
| 7 | epithelial cell differentiation involved in kidney development (GO:0035850) | 5.20629116 |
| 8 | regulation of relaxation of muscle (GO:1901077) | 5.12978208 |
| 9 | skeletal muscle contraction (GO:0003009) | 5.02832480 |
| 10 | regulation of skeletal muscle contraction (GO:0014819) | 4.95990346 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.95520580 |
| 12 | striated muscle contraction (GO:0006941) | 4.95396108 |
| 13 | cardiac muscle contraction (GO:0060048) | 4.88648510 |
| 14 | creatine metabolic process (GO:0006600) | 4.68074648 |
| 15 | regulation of axon guidance (GO:1902667) | 4.61628855 |
| 16 | actin filament-based movement (GO:0030048) | 4.59984502 |
| 17 | regulation of cell communication by electrical coupling (GO:0010649) | 4.57039926 |
| 18 | endothelial cell chemotaxis (GO:0035767) | 4.48273280 |
| 19 | regulation of actin filament-based movement (GO:1903115) | 4.41746056 |
| 20 | NADH metabolic process (GO:0006734) | 4.36738435 |
| 21 | cardiac muscle hypertrophy (GO:0003300) | 4.26556489 |
| 22 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.19560275 |
| 23 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.18349310 |
| 24 | negative regulation of axon guidance (GO:1902668) | 4.11225427 |
| 25 | striated muscle hypertrophy (GO:0014897) | 4.08807615 |
| 26 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.03920513 |
| 27 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.02838780 |
| 28 | actomyosin structure organization (GO:0031032) | 4.00453086 |
| 29 | positive regulation of p38MAPK cascade (GO:1900745) | 3.99042160 |
| 30 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.95562688 |
| 31 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.90034936 |
| 32 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.87766787 |
| 33 | muscle contraction (GO:0006936) | 3.82413110 |
| 34 | coronary vasculature morphogenesis (GO:0060977) | 3.67233493 |
| 35 | muscle hypertrophy (GO:0014896) | 3.67221102 |
| 36 | regulation of the force of heart contraction (GO:0002026) | 3.62960881 |
| 37 | regulation of p38MAPK cascade (GO:1900744) | 3.60589174 |
| 38 | stress fiber assembly (GO:0043149) | 3.58468451 |
| 39 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.58156895 |
| 40 | cell adhesion mediated by integrin (GO:0033627) | 3.51687560 |
| 41 | response to muscle activity (GO:0014850) | 3.50023527 |
| 42 | muscle system process (GO:0003012) | 3.47499230 |
| 43 | response to inactivity (GO:0014854) | 3.47413169 |
| 44 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.46284427 |
| 45 | axon extension involved in axon guidance (GO:0048846) | 3.46284427 |
| 46 | cardiac muscle adaptation (GO:0014887) | 3.46223397 |
| 47 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.46223397 |
| 48 | muscle hypertrophy in response to stress (GO:0003299) | 3.46223397 |
| 49 | plasma membrane repair (GO:0001778) | 3.44550048 |
| 50 | protein localization to endosome (GO:0036010) | 3.43998063 |
| 51 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.43726798 |
| 52 | skeletal muscle fiber development (GO:0048741) | 3.38904678 |
| 53 | lymphangiogenesis (GO:0001946) | 3.36611856 |
| 54 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.36488391 |
| 55 | renal filtration (GO:0097205) | 3.35946583 |
| 56 | regulation of striated muscle contraction (GO:0006942) | 3.30480879 |
| 57 | striated muscle adaptation (GO:0014888) | 3.29782236 |
| 58 | kidney mesenchyme development (GO:0072074) | 3.27655084 |
| 59 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.26670906 |
| 60 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.26497725 |
| 61 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.26497725 |
| 62 | activation of Rac GTPase activity (GO:0032863) | 3.25302674 |
| 63 | skeletal muscle adaptation (GO:0043501) | 3.22518987 |
| 64 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.21496773 |
| 65 | venous blood vessel morphogenesis (GO:0048845) | 3.19644379 |
| 66 | protein heterotrimerization (GO:0070208) | 3.18006572 |
| 67 | glycogen catabolic process (GO:0005980) | 3.17894513 |
| 68 | regulation of glomerular filtration (GO:0003093) | 3.15672772 |
| 69 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.10615103 |
| 70 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.07958015 |
| 71 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.07802261 |
| 72 | myotube cell development (GO:0014904) | 3.05092257 |
| 73 | muscle tissue morphogenesis (GO:0060415) | 3.04162299 |
| 74 | metanephric mesenchyme development (GO:0072075) | 3.03843577 |
| 75 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.01075933 |
| 76 | glucan catabolic process (GO:0009251) | 3.00671389 |
| 77 | adult heart development (GO:0007512) | 2.98359143 |
| 78 | positive regulation of vascular permeability (GO:0043117) | 2.97638758 |
| 79 | carnitine shuttle (GO:0006853) | 2.95072288 |
| 80 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.94400097 |
| 81 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.94400097 |
| 82 | myoblast fusion (GO:0007520) | 2.91925905 |
| 83 | cellular response to epinephrine stimulus (GO:0071872) | 2.89451448 |
| 84 | skeletal muscle tissue development (GO:0007519) | 2.85956857 |
| 85 | angiotensin maturation (GO:0002003) | 2.85804912 |
| 86 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.85358405 |
| 87 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.84255161 |
| 88 | synaptic vesicle maturation (GO:0016188) | 2.81735943 |
| 89 | regulation of membrane repolarization (GO:0060306) | 2.81684385 |
| 90 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.80788562 |
| 91 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.80701466 |
| 92 | detection of calcium ion (GO:0005513) | 2.79387335 |
| 93 | response to epinephrine (GO:0071871) | 2.79119963 |
| 94 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.77410539 |
| 95 | cellular polysaccharide catabolic process (GO:0044247) | 2.76254617 |
| 96 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.75662621 |
| 97 | blood vessel endothelial cell migration (GO:0043534) | 2.75194864 |
| 98 | muscle fiber development (GO:0048747) | 2.74981405 |
| 99 | relaxation of cardiac muscle (GO:0055119) | 2.74124479 |
| 100 | relaxation of muscle (GO:0090075) | 2.73972319 |
| 101 | positive regulation of axon extension (GO:0045773) | 2.72537365 |
| 102 | muscle adaptation (GO:0043500) | 2.71681154 |
| 103 | regulation of synapse structural plasticity (GO:0051823) | 2.70606763 |
| 104 | regulation of sequestering of triglyceride (GO:0010889) | 2.70202982 |
| 105 | neuronal action potential propagation (GO:0019227) | 2.70125536 |
| 106 | cardiac muscle cell development (GO:0055013) | 2.69434618 |
| 107 | glucan biosynthetic process (GO:0009250) | 2.67622068 |
| 108 | glycogen biosynthetic process (GO:0005978) | 2.67622068 |
| 109 | surfactant homeostasis (GO:0043129) | 2.67552835 |
| 110 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.66429025 |
| 111 | wound healing, spreading of epidermal cells (GO:0035313) | 2.65438026 |
| 112 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.63747552 |
| 113 | epithelial cell-cell adhesion (GO:0090136) | 2.63150430 |
| 114 | cellular potassium ion homeostasis (GO:0030007) | 2.62622730 |
| 115 | patterning of blood vessels (GO:0001569) | 2.62442757 |
| 116 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.60890167 |
| 117 | renal system process involved in regulation of blood volume (GO:0001977) | 2.60516788 |
| 118 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.59774542 |
| 119 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.59285553 |
| 120 | regulation of heart contraction (GO:0008016) | 2.58876170 |
| 121 | 2-oxoglutarate metabolic process (GO:0006103) | 2.57723730 |
| 122 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.57035132 |
| 123 | chemical homeostasis within a tissue (GO:0048875) | 2.56250158 |
| 124 | cell communication by electrical coupling (GO:0010644) | 2.56052307 |
| 125 | fatty acid transmembrane transport (GO:1902001) | 2.55461061 |
| 126 | cardiac cell development (GO:0055006) | 2.55065513 |
| 127 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.54639444 |
| 128 | lung vasculature development (GO:0060426) | 2.54243060 |
| 129 | regulation of muscle system process (GO:0090257) | 2.53661761 |
| 130 | positive regulation of myotube differentiation (GO:0010831) | 2.53283441 |
| 131 | cardiac muscle cell proliferation (GO:0060038) | 2.52210225 |
| 132 | cardiac myofibril assembly (GO:0055003) | 2.51448621 |
| 133 | regulation of heart rate (GO:0002027) | 2.49371121 |
| 134 | cell differentiation involved in kidney development (GO:0061005) | 2.49137265 |
| 135 | cell-substrate adherens junction assembly (GO:0007045) | 2.48636772 |
| 136 | focal adhesion assembly (GO:0048041) | 2.48636772 |
| 137 | locomotory exploration behavior (GO:0035641) | 2.48113045 |
| 138 | oxaloacetate metabolic process (GO:0006107) | 2.47026143 |
| 139 | negative regulation of protein localization to cell surface (GO:2000009) | 2.46380011 |
| 140 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.46025052 |
| 141 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.45885608 |
| 142 | regulation of vascular permeability (GO:0043114) | 2.45764983 |
| 143 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.45175759 |
| 144 | cardiac conduction (GO:0061337) | 2.44617760 |
| 145 | regulation of Rac protein signal transduction (GO:0035020) | 2.42598950 |
| 146 | syncytium formation (GO:0006949) | 2.41766973 |
| 147 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.41141841 |
| 148 | protein targeting to plasma membrane (GO:0072661) | 2.41101675 |
| 149 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.40457451 |
| 150 | negative regulation of vascular permeability (GO:0043116) | 2.39344299 |
| 151 | lymph vessel development (GO:0001945) | 2.39234425 |
| 152 | sprouting angiogenesis (GO:0002040) | 2.38680972 |
| 153 | establishment of nucleus localization (GO:0040023) | 2.38302718 |
| 154 | glutamate secretion (GO:0014047) | 2.35821840 |
| 155 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.35606789 |
| 156 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.34076945 |
| 157 | regulation of alkaline phosphatase activity (GO:0010692) | 2.33993234 |
| 158 | auditory receptor cell stereocilium organization (GO:0060088) | 2.31355410 |
| 159 | glomerular filtration (GO:0003094) | 2.29697415 |
| 160 | endothelium development (GO:0003158) | 2.29434275 |
| 161 | neuromuscular process controlling balance (GO:0050885) | 2.29141825 |
| 162 | activation of protein kinase A activity (GO:0034199) | 2.27896750 |
| 163 | vocalization behavior (GO:0071625) | 2.27003940 |
| 164 | camera-type eye morphogenesis (GO:0048593) | 2.26429074 |
| 165 | cell communication involved in cardiac conduction (GO:0086065) | 2.24925733 |
| 166 | actin cytoskeleton reorganization (GO:0031532) | 2.24878233 |
| 167 | endothelial cell migration (GO:0043542) | 2.24207740 |
| 168 | sodium ion export (GO:0071436) | 2.23866247 |
| 169 | collagen fibril organization (GO:0030199) | 2.23096258 |
| 170 | axonal fasciculation (GO:0007413) | 2.21793179 |
| 171 | apoptotic cell clearance (GO:0043277) | 2.19683503 |
| 172 | diaphragm development (GO:0060539) | 2.19086105 |
| 173 | skeletal muscle organ development (GO:0060538) | 2.18497137 |
| 174 | mesodermal cell differentiation (GO:0048333) | 2.18327209 |
| 175 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.18032461 |
| 176 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.17338269 |
| 177 | substrate-dependent cell migration (GO:0006929) | 2.17210710 |
| 178 | endocytic recycling (GO:0032456) | 2.16822627 |
| 179 | sarcomere organization (GO:0045214) | 2.15481642 |
| 180 | neuron recognition (GO:0008038) | 2.15366459 |
| 181 | positive regulation of adherens junction organization (GO:1903393) | 2.13766047 |
| 182 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.13365702 |
| 183 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.13210709 |
| 184 | semaphorin-plexin signaling pathway (GO:0071526) | 2.12159332 |
| 185 | glomerular visceral epithelial cell development (GO:0072015) | 15.1132244 |
| 186 | glomerular epithelial cell development (GO:0072310) | 13.4422790 |
| 187 | glomerular basement membrane development (GO:0032836) | 11.8787693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.05180739 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.03826035 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.60741159 |
| 4 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.47028075 |
| 5 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.47028075 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.38526002 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.32986492 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.23424052 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.21919856 |
| 10 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.17590800 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.16775340 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.15710112 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.12133199 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.08086561 |
| 15 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.06429981 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.00437990 |
| 17 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 2.00064110 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.98605565 |
| 19 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.93743973 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.90692746 |
| 21 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.88575032 |
| 22 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.86990490 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.85871844 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.85111173 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.82977964 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.80998264 |
| 27 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.77321161 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.76899545 |
| 29 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76193323 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.75604895 |
| 31 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.75128244 |
| 32 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.74874086 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.70170985 |
| 34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.59690194 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59353573 |
| 36 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.58168187 |
| 37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56976386 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56602554 |
| 39 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.52800199 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51981787 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.49028671 |
| 42 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.48265650 |
| 43 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.46310657 |
| 44 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.44566717 |
| 45 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.44053335 |
| 46 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.43667027 |
| 47 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.40709024 |
| 48 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40480525 |
| 49 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.38151953 |
| 50 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.36877282 |
| 51 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.36214388 |
| 52 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.35617530 |
| 53 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35365092 |
| 54 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.34730391 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34118075 |
| 56 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28760589 |
| 57 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28595760 |
| 58 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27535319 |
| 59 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27238788 |
| 60 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.24417823 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24288628 |
| 62 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.23320811 |
| 63 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22470145 |
| 64 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.20022944 |
| 65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.18544895 |
| 66 | RXR_22108803_ChIP-Seq_LS180_Human | 1.16157767 |
| 67 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15968423 |
| 68 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15904262 |
| 69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15412652 |
| 70 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14366791 |
| 71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13390246 |
| 72 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12549378 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11926025 |
| 74 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11062694 |
| 75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10883364 |
| 76 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.09978786 |
| 77 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09705928 |
| 78 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09239414 |
| 79 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07601966 |
| 80 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07601966 |
| 81 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.06485156 |
| 82 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06374384 |
| 83 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05901981 |
| 84 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.05115408 |
| 85 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.04892929 |
| 86 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.04383045 |
| 87 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03342737 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01705288 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01640164 |
| 90 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01125668 |
| 91 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01081747 |
| 92 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00852134 |
| 93 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00644437 |
| 94 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00448854 |
| 95 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00299191 |
| 96 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00123774 |
| 97 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.98882305 |
| 98 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98332048 |
| 99 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98329679 |
| 100 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98291834 |
| 101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97951555 |
| 102 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97518314 |
| 103 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97484802 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96990600 |
| 105 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.96788136 |
| 106 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96610294 |
| 107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96484326 |
| 108 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96327682 |
| 109 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.96302261 |
| 110 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95991180 |
| 111 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.95451422 |
| 112 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.95232868 |
| 113 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.93891276 |
| 114 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.93544571 |
| 115 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93151377 |
| 116 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.92728058 |
| 117 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91925938 |
| 118 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91123091 |
| 119 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90501239 |
| 120 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.90388286 |
| 121 | AR_19668381_ChIP-Seq_PC3_Human | 0.90156218 |
| 122 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.89511318 |
| 123 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88902154 |
| 124 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.88715781 |
| 125 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88711603 |
| 126 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88603241 |
| 127 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.88539901 |
| 128 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87655031 |
| 129 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.86751209 |
| 130 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.86095279 |
| 131 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85676768 |
| 132 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.85536531 |
| 133 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83260005 |
| 134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82326538 |
| 135 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81096236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005623_abnormal_meninges_morphology | 4.96258690 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.28576662 |
| 3 | MP0004084_abnormal_cardiac_muscle | 3.85495177 |
| 4 | MP0004272_abnormal_basement_membrane | 3.61199643 |
| 5 | MP0010368_abnormal_lymphatic_system | 3.19323078 |
| 6 | MP0004036_abnormal_muscle_relaxation | 2.85711588 |
| 7 | MP0005503_abnormal_tendon_morphology | 2.57850391 |
| 8 | MP0000751_myopathy | 2.51401845 |
| 9 | MP0005670_abnormal_white_adipose | 2.42381656 |
| 10 | MP0001879_abnormal_lymphatic_vessel | 2.41267547 |
| 11 | MP0004510_myositis | 2.19340300 |
| 12 | MP0002332_abnormal_exercise_endurance | 2.12721385 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.06450952 |
| 14 | MP0003283_abnormal_digestive_organ | 1.92688585 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 1.89764552 |
| 16 | MP0005451_abnormal_body_composition | 1.85647294 |
| 17 | MP0009384_cardiac_valve_regurgitation | 1.85575636 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 1.83593460 |
| 19 | MP0000013_abnormal_adipose_tissue | 1.83062044 |
| 20 | MP0003279_aneurysm | 1.79296797 |
| 21 | MP0000537_abnormal_urethra_morphology | 1.79108904 |
| 22 | MP0005167_abnormal_blood-brain_barrier | 1.78141933 |
| 23 | MP0000534_abnormal_ureter_morphology | 1.77483568 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.75599154 |
| 25 | MP0000747_muscle_weakness | 1.71449906 |
| 26 | * MP0003635_abnormal_synaptic_transmissio | 1.69658197 |
| 27 | MP0000230_abnormal_systemic_arterial | 1.68357082 |
| 28 | MP0004233_abnormal_muscle_weight | 1.64550636 |
| 29 | MP0006138_congestive_heart_failure | 1.62260583 |
| 30 | MP0003942_abnormal_urinary_system | 1.61117047 |
| 31 | MP0005620_abnormal_muscle_contractility | 1.55292940 |
| 32 | MP0003091_abnormal_cell_migration | 1.53853003 |
| 33 | MP0000749_muscle_degeneration | 1.53402289 |
| 34 | MP0004087_abnormal_muscle_fiber | 1.53287075 |
| 35 | MP0004484_altered_response_of | 1.49674636 |
| 36 | MP0004215_abnormal_myocardial_fiber | 1.49133786 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.47235677 |
| 38 | MP0008775_abnormal_heart_ventricle | 1.46168897 |
| 39 | MP0002972_abnormal_cardiac_muscle | 1.46030033 |
| 40 | MP0005666_abnormal_adipose_tissue | 1.45927661 |
| 41 | MP0002295_abnormal_pulmonary_circulatio | 1.45722228 |
| 42 | MP0008961_abnormal_basal_metabolism | 1.43307747 |
| 43 | MP0010030_abnormal_orbit_morphology | 1.43304437 |
| 44 | MP0002127_abnormal_cardiovascular_syste | 1.42635554 |
| 45 | MP0005275_abnormal_skin_tensile | 1.40268349 |
| 46 | MP0005385_cardiovascular_system_phenoty | 1.39253123 |
| 47 | MP0001544_abnormal_cardiovascular_syste | 1.39253123 |
| 48 | MP0003879_abnormal_hair_cell | 1.36884785 |
| 49 | MP0005330_cardiomyopathy | 1.32262026 |
| 50 | * MP0002063_abnormal_learning/memory/cond | 1.32078390 |
| 51 | MP0002269_muscular_atrophy | 1.29888586 |
| 52 | MP0002971_abnormal_brown_adipose | 1.29190925 |
| 53 | MP0003137_abnormal_impulse_conducting | 1.25887767 |
| 54 | MP0004130_abnormal_muscle_cell | 1.25123650 |
| 55 | MP0005187_abnormal_penis_morphology | 1.21819220 |
| 56 | MP0001958_emphysema | 1.19735527 |
| 57 | MP0004270_analgesia | 1.19393906 |
| 58 | MP0002822_catalepsy | 1.18109313 |
| 59 | MP0010630_abnormal_cardiac_muscle | 1.15306485 |
| 60 | MP0001661_extended_life_span | 1.15058054 |
| 61 | MP0004085_abnormal_heartbeat | 1.14055538 |
| 62 | MP0009745_abnormal_behavioral_response | 1.13398561 |
| 63 | MP0002128_abnormal_blood_circulation | 1.12591957 |
| 64 | MP0001299_abnormal_eye_distance/ | 1.10205724 |
| 65 | MP0002108_abnormal_muscle_morphology | 1.10175802 |
| 66 | MP0000767_abnormal_smooth_muscle | 1.09834011 |
| 67 | MP0000003_abnormal_adipose_tissue | 1.09316264 |
| 68 | MP0003385_abnormal_body_wall | 1.09027457 |
| 69 | MP0003646_muscle_fatigue | 1.07078856 |
| 70 | MP0004858_abnormal_nervous_system | 1.06488085 |
| 71 | MP0002135_abnormal_kidney_morphology | 1.06288213 |
| 72 | MP0000759_abnormal_skeletal_muscle | 1.05638496 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.04452844 |
| 74 | MP0005369_muscle_phenotype | 1.03269057 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 1.01507352 |
| 76 | MP0002106_abnormal_muscle_physiology | 1.00756667 |
| 77 | MP0004145_abnormal_muscle_electrophysio | 0.99188376 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.99133376 |
| 79 | MP0005409_darkened_coat_color | 0.96790768 |
| 80 | MP0005165_increased_susceptibility_to | 0.94655500 |
| 81 | MP0002064_seizures | 0.93178024 |
| 82 | MP0002896_abnormal_bone_mineralization | 0.92999172 |
| 83 | MP0002090_abnormal_vision | 0.91911514 |
| 84 | MP0003941_abnormal_skin_development | 0.90042603 |
| 85 | MP0001614_abnormal_blood_vessel | 0.89557279 |
| 86 | MP0005423_abnormal_somatic_nervous | 0.89013966 |
| 87 | MP0001486_abnormal_startle_reflex | 0.88845886 |
| 88 | MP0003115_abnormal_respiratory_system | 0.86650750 |
| 89 | MP0005595_abnormal_vascular_smooth | 0.86575048 |
| 90 | MP0005508_abnormal_skeleton_morphology | 0.86262563 |
| 91 | MP0001501_abnormal_sleep_pattern | 0.86059430 |
| 92 | MP0003950_abnormal_plasma_membrane | 0.85596002 |
| 93 | MP0003075_altered_response_to | 0.84527743 |
| 94 | MP0003828_pulmonary_edema | 0.83574253 |
| 95 | MP0000750_abnormal_muscle_regeneration | 0.82988840 |
| 96 | MP0002909_abnormal_adrenal_gland | 0.82979891 |
| 97 | MP0001440_abnormal_grooming_behavior | 0.82855515 |
| 98 | MP0000678_abnormal_parathyroid_gland | 0.79602104 |
| 99 | MP0009643_abnormal_urine_homeostasis | 0.79076133 |
| 100 | MP0005375_adipose_tissue_phenotype | 0.78136773 |
| 101 | MP0000733_abnormal_muscle_development | 0.78060794 |
| 102 | MP0002925_abnormal_cardiovascular_devel | 0.77976491 |
| 103 | MP0003880_abnormal_central_pattern | 0.77766543 |
| 104 | MP0003329_amyloid_beta_deposits | 0.77131600 |
| 105 | MP0000163_abnormal_cartilage_morphology | 0.77121454 |
| 106 | MP0005197_abnormal_uvea_morphology | 0.76740896 |
| 107 | MP0001784_abnormal_fluid_regulation | 0.76440313 |
| 108 | MP0003690_abnormal_glial_cell | 0.75845157 |
| 109 | MP0003045_fibrosis | 0.75546603 |
| 110 | MP0005535_abnormal_body_temperature | 0.72948581 |
| 111 | MP0002234_abnormal_pharynx_morphology | 0.72826721 |
| 112 | * MP0002572_abnormal_emotion/affect_behav | 0.72211794 |
| 113 | MP0009250_abnormal_appendicular_skeleto | 0.72088894 |
| 114 | MP0000579_abnormal_nail_morphology | 0.71294074 |
| 115 | MP0008569_lethality_at_weaning | 0.69879059 |
| 116 | MP0005266_abnormal_metabolism | 0.69445157 |
| 117 | MP0000266_abnormal_heart_morphology | 0.68020404 |
| 118 | MP0005166_decreased_susceptibility_to | 0.67076136 |
| 119 | MP0002734_abnormal_mechanical_nocicepti | 0.66372491 |
| 120 | MP0002272_abnormal_nervous_system | 0.62872486 |
| 121 | MP0008874_decreased_physiological_sensi | 0.61526647 |
| 122 | MP0002933_joint_inflammation | 0.60678966 |
| 123 | MP0001502_abnormal_circadian_rhythm | 0.59908677 |
| 124 | MP0002876_abnormal_thyroid_physiology | 0.57475177 |
| 125 | MP0009840_abnormal_foam_cell | 0.53535580 |
| 126 | MP0000343_altered_response_to | 0.53172489 |
| 127 | MP0000249_abnormal_blood_vessel | 0.51531428 |
| 128 | MP0002078_abnormal_glucose_homeostasis | 0.49127569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mesangial abnormality (HP:0001966) | 8.95644316 |
| 2 | Focal segmental glomerulosclerosis (HP:0000097) | 8.14478268 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 7.97425739 |
| 4 | Nemaline bodies (HP:0003798) | 7.84036544 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.74821689 |
| 6 | Glomerulosclerosis (HP:0000096) | 6.21635070 |
| 7 | Hypoalbuminemia (HP:0003073) | 6.13685562 |
| 8 | Abnormal albumin level (HP:0012116) | 6.13685562 |
| 9 | Nephritis (HP:0000123) | 4.37838777 |
| 10 | Stage 5 chronic kidney disease (HP:0003774) | 4.34252156 |
| 11 | Distal lower limb muscle weakness (HP:0009053) | 4.27500291 |
| 12 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.26765956 |
| 13 | Myopathic facies (HP:0002058) | 4.22349373 |
| 14 | Round ear (HP:0100830) | 4.14869350 |
| 15 | Neck muscle weakness (HP:0000467) | 3.94341832 |
| 16 | Distal arthrogryposis (HP:0005684) | 3.94126958 |
| 17 | Rapidly progressive (HP:0003678) | 3.77791256 |
| 18 | Rhabdomyolysis (HP:0003201) | 3.76505182 |
| 19 | Myoglobinuria (HP:0002913) | 3.76429994 |
| 20 | Glomerulonephritis (HP:0000099) | 3.68003781 |
| 21 | Lymphangioma (HP:0100764) | 3.51793125 |
| 22 | Ulnar deviation of the wrist (HP:0003049) | 3.24306142 |
| 23 | Rimmed vacuoles (HP:0003805) | 3.13745602 |
| 24 | Nephrotic syndrome (HP:0000100) | 3.13567859 |
| 25 | Tubular atrophy (HP:0000092) | 3.13068069 |
| 26 | EMG: neuropathic changes (HP:0003445) | 3.11565264 |
| 27 | Broad metatarsal (HP:0001783) | 3.10839459 |
| 28 | Sudden death (HP:0001699) | 3.04550876 |
| 29 | Muscle stiffness (HP:0003552) | 3.03834512 |
| 30 | Frequent falls (HP:0002359) | 3.00723779 |
| 31 | Nonprogressive disorder (HP:0003680) | 2.97506587 |
| 32 | Lipoatrophy (HP:0100578) | 2.96165036 |
| 33 | Hypoproteinemia (HP:0003075) | 2.93669148 |
| 34 | Protrusio acetabuli (HP:0003179) | 2.93127752 |
| 35 | Muscle fiber splitting (HP:0003555) | 2.86341380 |
| 36 | Spinal rigidity (HP:0003306) | 2.83995059 |
| 37 | Dilated cardiomyopathy (HP:0001644) | 2.81664087 |
| 38 | Hip contracture (HP:0003273) | 2.78779185 |
| 39 | Hyporeflexia of lower limbs (HP:0002600) | 2.75479427 |
| 40 | Ankle contracture (HP:0006466) | 2.75355912 |
| 41 | Shallow orbits (HP:0000586) | 2.75167517 |
| 42 | Neonatal respiratory distress (HP:0002643) | 2.73805250 |
| 43 | Areflexia of lower limbs (HP:0002522) | 2.68607652 |
| 44 | Aortic aneurysm (HP:0004942) | 2.68294110 |
| 45 | Exercise-induced myalgia (HP:0003738) | 2.65171299 |
| 46 | Increased connective tissue (HP:0009025) | 2.56894052 |
| 47 | Abnormality of the foot musculature (HP:0001436) | 2.55371639 |
| 48 | Difficulty running (HP:0009046) | 2.50495953 |
| 49 | Calcaneovalgus deformity (HP:0001848) | 2.49727228 |
| 50 | Bundle branch block (HP:0011710) | 2.48748576 |
| 51 | Foot dorsiflexor weakness (HP:0009027) | 2.46464921 |
| 52 | Generalized muscle weakness (HP:0003324) | 2.46235155 |
| 53 | Proteinuria (HP:0000093) | 2.46127731 |
| 54 | Right ventricular cardiomyopathy (HP:0011663) | 2.43944840 |
| 55 | Type 1 muscle fiber predominance (HP:0003803) | 2.43650356 |
| 56 | Metaphyseal dysplasia (HP:0100255) | 2.43465372 |
| 57 | Premature rupture of membranes (HP:0001788) | 2.42462267 |
| 58 | Bulbar palsy (HP:0001283) | 2.41738979 |
| 59 | Coronal craniosynostosis (HP:0004440) | 2.38866120 |
| 60 | Slender build (HP:0001533) | 2.38053715 |
| 61 | Cerebral aneurysm (HP:0004944) | 2.37076155 |
| 62 | Increased variability in muscle fiber diameter (HP:0003557) | 2.36581608 |
| 63 | Corneal erosion (HP:0200020) | 2.28619471 |
| 64 | Myokymia (HP:0002411) | 2.27101795 |
| 65 | Difficulty climbing stairs (HP:0003551) | 2.24573708 |
| 66 | Aortic dissection (HP:0002647) | 2.21837446 |
| 67 | Exercise-induced muscle cramps (HP:0003710) | 2.19871535 |
| 68 | Deformed tarsal bones (HP:0008119) | 2.18561620 |
| 69 | Abnormality of the calf musculature (HP:0001430) | 2.17366629 |
| 70 | Atrial fibrillation (HP:0005110) | 2.15983306 |
| 71 | Aneurysm (HP:0002617) | 2.14388473 |
| 72 | Limited hip movement (HP:0008800) | 2.13836213 |
| 73 | Gowers sign (HP:0003391) | 2.11822885 |
| 74 | Obstructive sleep apnea (HP:0002870) | 2.11763808 |
| 75 | Polar cataract (HP:0010696) | 2.08117251 |
| 76 | Turricephaly (HP:0000262) | 2.07002347 |
| 77 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.06937446 |
| 78 | Hematuria (HP:0000790) | 2.05880476 |
| 79 | Visceral angiomatosis (HP:0100761) | 2.05713941 |
| 80 | Primary atrial arrhythmia (HP:0001692) | 2.05289580 |
| 81 | Calf muscle hypertrophy (HP:0008981) | 2.03217991 |
| 82 | Heart block (HP:0012722) | 2.00143881 |
| 83 | Malignant hyperthermia (HP:0002047) | 1.98147925 |
| 84 | Abnormal atrioventricular conduction (HP:0005150) | 1.97575174 |
| 85 | Venous insufficiency (HP:0005293) | 1.96428073 |
| 86 | Metaphyseal cupping (HP:0003021) | 1.96023572 |
| 87 | Distal lower limb amyotrophy (HP:0008944) | 1.95221200 |
| 88 | Atrioventricular block (HP:0001678) | 1.95089411 |
| 89 | Ventricular fibrillation (HP:0001663) | 1.94574338 |
| 90 | Limb-girdle muscle atrophy (HP:0003797) | 1.94148944 |
| 91 | EMG: myopathic abnormalities (HP:0003458) | 1.93514305 |
| 92 | Vascular tortuosity (HP:0004948) | 1.93280598 |
| 93 | Supraventricular arrhythmia (HP:0005115) | 1.93112027 |
| 94 | Hyperkalemia (HP:0002153) | 1.92830941 |
| 95 | Prolonged QT interval (HP:0001657) | 1.90809881 |
| 96 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.90704859 |
| 97 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.90651036 |
| 98 | Knee flexion contracture (HP:0006380) | 1.90638353 |
| 99 | Muscular dystrophy (HP:0003560) | 1.89408365 |
| 100 | Ventricular tachycardia (HP:0004756) | 1.89360460 |
| 101 | Pterygium (HP:0001059) | 1.88924370 |
| 102 | Lower limb amyotrophy (HP:0007210) | 1.88866844 |
| 103 | Supraventricular tachycardia (HP:0004755) | 1.88721714 |
| 104 | Focal motor seizures (HP:0011153) | 1.87672298 |
| 105 | Hemangiomatosis (HP:0007461) | 1.87038515 |
| 106 | Arterial tortuosity (HP:0005116) | 1.84380708 |
| 107 | Subaortic stenosis (HP:0001682) | 1.84368957 |
| 108 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.84368957 |
| 109 | Syncope (HP:0001279) | 1.81934097 |
| 110 | Distal upper limb amyotrophy (HP:0007149) | 1.81486120 |
| 111 | Upper limb amyotrophy (HP:0009129) | 1.81486120 |
| 112 | Myotonia (HP:0002486) | 1.81414831 |
| 113 | Absent phalangeal crease (HP:0006109) | 1.81246331 |
| 114 | Increased circulating renin level (HP:0000848) | 1.81177804 |
| 115 | Waddling gait (HP:0002515) | 1.79805076 |
| 116 | Proximal amyotrophy (HP:0007126) | 1.79496014 |
| 117 | Oligomenorrhea (HP:0000876) | 1.79472314 |
| 118 | Ragged-red muscle fibers (HP:0003200) | 1.79159757 |
| 119 | Venous abnormality (HP:0002624) | 1.77933772 |
| 120 | Polycythemia (HP:0001901) | 1.76958332 |
| 121 | Weak cry (HP:0001612) | 1.76347674 |
| 122 | Abnormal finger flexion creases (HP:0006143) | 1.76083375 |
| 123 | Exostoses (HP:0100777) | 1.75947160 |
| 124 | Overgrowth (HP:0001548) | 1.75586107 |
| 125 | Abnormal EKG (HP:0003115) | 1.75419120 |
| 126 | Deep venous thrombosis (HP:0002625) | 1.74780509 |
| 127 | Persistence of primary teeth (HP:0006335) | 1.74545361 |
| 128 | Hypoplasia of the iris (HP:0007676) | 1.70484407 |
| 129 | Tubulointerstitial fibrosis (HP:0005576) | 1.68793327 |
| 130 | Ventricular arrhythmia (HP:0004308) | 1.66266505 |
| 131 | Hypoplastic ischia (HP:0003175) | 1.66109444 |
| 132 | Atrophic scars (HP:0001075) | 1.65558821 |
| 133 | Bladder diverticulum (HP:0000015) | 1.64797924 |
| 134 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.64653321 |
| 135 | Fetal akinesia sequence (HP:0001989) | 1.64232019 |
| 136 | Renal duplication (HP:0000075) | 1.63752430 |
| 137 | Asymmetric septal hypertrophy (HP:0001670) | 1.61786923 |
| 138 | Steppage gait (HP:0003376) | 1.59633248 |
| 139 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.59591188 |
| 140 | Wrist flexion contracture (HP:0001239) | 1.58883821 |
| 141 | Abnormal tarsal ossification (HP:0008369) | 1.57680713 |
| 142 | Bronchomalacia (HP:0002780) | 1.56783640 |
| 143 | Buphthalmos (HP:0000557) | 1.54727607 |
| 144 | Scapular winging (HP:0003691) | 1.54562557 |
| 145 | Hematochezia (HP:0002573) | 1.54372579 |
| 146 | Limb-girdle muscle weakness (HP:0003325) | 1.52830810 |
| 147 | Fatigable weakness (HP:0003473) | 1.50471960 |
| 148 | Abnormality of the neuromuscular junction (HP:0003398) | 1.50471960 |
| 149 | Ankle clonus (HP:0011448) | 1.50112079 |
| 150 | Sudden cardiac death (HP:0001645) | 1.49740029 |
| 151 | Dysmetric saccades (HP:0000641) | 1.49310225 |
| 152 | Stridor (HP:0010307) | 1.44317809 |
| 153 | Abnormality of the calcaneus (HP:0008364) | 1.43193808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB2 | 3.62863437 |
| 2 | EPHA4 | 2.95138930 |
| 3 | TTN | 2.57846879 |
| 4 | TRIB3 | 2.55567958 |
| 5 | WNK4 | 2.55521027 |
| 6 | TIE1 | 2.55386800 |
| 7 | NTRK3 | 2.54478163 |
| 8 | MYLK | 2.44057243 |
| 9 | PRKD3 | 2.27467406 |
| 10 | PAK4 | 2.01396197 |
| 11 | OXSR1 | 2.00789840 |
| 12 | PDGFRA | 1.95276116 |
| 13 | DMPK | 1.85112125 |
| 14 | MAP3K7 | 1.74880213 |
| 15 | NTRK1 | 1.70251460 |
| 16 | KSR2 | 1.66847827 |
| 17 | TGFBR2 | 1.65207040 |
| 18 | RIPK1 | 1.64561740 |
| 19 | LATS2 | 1.62458206 |
| 20 | STK39 | 1.59092103 |
| 21 | PAK3 | 1.56146003 |
| 22 | PIK3CG | 1.52605525 |
| 23 | PAK6 | 1.48358608 |
| 24 | PINK1 | 1.48194868 |
| 25 | MAP3K9 | 1.47286656 |
| 26 | PHKG1 | 1.46725101 |
| 27 | PHKG2 | 1.46725101 |
| 28 | LATS1 | 1.46547697 |
| 29 | FER | 1.45802868 |
| 30 | PRPF4B | 1.41906994 |
| 31 | DAPK2 | 1.40488669 |
| 32 | DDR2 | 1.39860701 |
| 33 | PTK2B | 1.39503740 |
| 34 | TRPM7 | 1.31892106 |
| 35 | MAPKAPK3 | 1.30904928 |
| 36 | LMTK2 | 1.26383949 |
| 37 | CAMK2B | 1.26055134 |
| 38 | PRKCH | 1.21797099 |
| 39 | ROCK1 | 1.17453060 |
| 40 | CAMKK1 | 1.17126862 |
| 41 | STK38 | 1.14506863 |
| 42 | LIMK1 | 1.09513426 |
| 43 | MARK2 | 1.08053022 |
| 44 | MUSK | 1.07649252 |
| 45 | EPHB1 | 1.06013976 |
| 46 | TYRO3 | 1.04963175 |
| 47 | EEF2K | 1.04493738 |
| 48 | CAMK2G | 1.02014004 |
| 49 | PKN2 | 1.01650756 |
| 50 | MAPK7 | 1.00244455 |
| 51 | OBSCN | 0.99947283 |
| 52 | TAOK1 | 0.99518300 |
| 53 | CDK19 | 0.98570128 |
| 54 | MAP3K2 | 0.98553735 |
| 55 | BMX | 0.98140603 |
| 56 | PRKAA2 | 0.95979703 |
| 57 | MAP2K3 | 0.95725662 |
| 58 | KDR | 0.92945815 |
| 59 | NME1 | 0.91373565 |
| 60 | CDK5 | 0.89530148 |
| 61 | PAK2 | 0.86702718 |
| 62 | MAP2K1 | 0.86519045 |
| 63 | CAMK1 | 0.85173999 |
| 64 | MINK1 | 0.84559108 |
| 65 | PTK2 | 0.84185929 |
| 66 | ICK | 0.83024451 |
| 67 | MAP3K4 | 0.82649442 |
| 68 | MAP3K13 | 0.82573069 |
| 69 | PDPK1 | 0.82279950 |
| 70 | NEK9 | 0.81042309 |
| 71 | NEK1 | 0.80282471 |
| 72 | PTK6 | 0.79462978 |
| 73 | CAMK2D | 0.78703234 |
| 74 | MAP3K6 | 0.78045425 |
| 75 | TESK1 | 0.77698861 |
| 76 | ARAF | 0.76600786 |
| 77 | SIK1 | 0.75862980 |
| 78 | WNK1 | 0.75700535 |
| 79 | PRKAA1 | 0.75331155 |
| 80 | PRKD1 | 0.75322223 |
| 81 | RET | 0.74424038 |
| 82 | PDK2 | 0.72886287 |
| 83 | MAPK4 | 0.72526155 |
| 84 | KSR1 | 0.72207313 |
| 85 | PDGFRB | 0.69300958 |
| 86 | MOS | 0.67886489 |
| 87 | MAP2K6 | 0.67680993 |
| 88 | UHMK1 | 0.65846001 |
| 89 | PRKCE | 0.63479694 |
| 90 | CAMK4 | 0.63261301 |
| 91 | PRKD2 | 0.63181717 |
| 92 | PKN1 | 0.62952049 |
| 93 | PRKG2 | 0.62615228 |
| 94 | FGFR1 | 0.62390699 |
| 95 | MAP3K1 | 0.62008899 |
| 96 | CDK15 | 0.60929195 |
| 97 | ERN1 | 0.60553631 |
| 98 | MAPK12 | 0.60205523 |
| 99 | PDK1 | 0.59715571 |
| 100 | PIK3CA | 0.58925553 |
| 101 | CAMK1G | 0.58202342 |
| 102 | CDK18 | 0.57241872 |
| 103 | EPHA3 | 0.56001299 |
| 104 | SGK223 | 0.55623081 |
| 105 | SGK494 | 0.55623081 |
| 106 | CAMK2A | 0.55435703 |
| 107 | CDK14 | 0.55145732 |
| 108 | STK11 | 0.54809259 |
| 109 | MAP2K4 | 0.54523659 |
| 110 | MARK1 | 0.53813508 |
| 111 | ROCK2 | 0.53802411 |
| 112 | CDC42BPA | 0.53464020 |
| 113 | FES | 0.52971941 |
| 114 | CDK11A | 0.52178601 |
| 115 | DAPK3 | 0.51383166 |
| 116 | AKT2 | 0.51044281 |
| 117 | SGK3 | 0.49807271 |
| 118 | SIK2 | 0.49545925 |
| 119 | JAK1 | 0.49278568 |
| 120 | RPS6KA2 | 0.49217802 |
| 121 | SGK2 | 0.47980793 |
| 122 | FGFR4 | 0.47893108 |
| 123 | PLK2 | 0.47468125 |
| 124 | FGFR2 | 0.46666656 |
| 125 | FYN | 0.46087798 |
| 126 | PRKG1 | 0.45972610 |
| 127 | NTRK2 | 0.45765627 |
| 128 | SRC | 0.45383891 |
| 129 | PDK4 | 0.45075812 |
| 130 | PDK3 | 0.45075812 |
| 131 | MAPK10 | 0.43232180 |
| 132 | SGK1 | 0.42615416 |
| 133 | GRK5 | 0.41634450 |
| 134 | RPS6KA3 | 0.41052405 |
| 135 | MST1R | 0.40897626 |
| 136 | CAMKK2 | 0.40728289 |
| 137 | MTOR | 0.39218717 |
| 138 | MAPK11 | 0.39177998 |
| 139 | MET | 0.36868700 |
| 140 | RPS6KC1 | 0.34003796 |
| 141 | RPS6KL1 | 0.34003796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.63937326 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.50515255 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.41057181 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.28420935 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.16435629 |
| 6 | Focal adhesion_Homo sapiens_hsa04510 | 1.94207798 |
| 7 | Axon guidance_Homo sapiens_hsa04360 | 1.94089635 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.83594682 |
| 9 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.75612419 |
| 10 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.69923458 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.67076048 |
| 12 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.66476985 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 1.65520464 |
| 14 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.64392073 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.62450925 |
| 16 | Amoebiasis_Homo sapiens_hsa05146 | 1.60484014 |
| 17 | Long-term potentiation_Homo sapiens_hsa04720 | 1.55862983 |
| 18 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.55684264 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.52943167 |
| 20 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47014957 |
| 21 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.46336807 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.44393410 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.44303706 |
| 24 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.43175910 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.42958443 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.41676950 |
| 27 | Salivary secretion_Homo sapiens_hsa04970 | 1.38807525 |
| 28 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.37837930 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.35989028 |
| 30 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.26145935 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.25560052 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.22700915 |
| 33 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.22697341 |
| 34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.21209046 |
| 35 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.20447146 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.20248137 |
| 37 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.19298153 |
| 38 | Morphine addiction_Homo sapiens_hsa05032 | 1.18803039 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.17639502 |
| 40 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.17101859 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16209038 |
| 42 | GABAergic synapse_Homo sapiens_hsa04727 | 1.15704706 |
| 43 | Adherens junction_Homo sapiens_hsa04520 | 1.15238195 |
| 44 | Gap junction_Homo sapiens_hsa04540 | 1.15235482 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.14816780 |
| 46 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.13666231 |
| 47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.13473969 |
| 48 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.09640411 |
| 49 | Glioma_Homo sapiens_hsa05214 | 1.08679856 |
| 50 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.07679115 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.07152834 |
| 52 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.06913798 |
| 53 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.06546553 |
| 54 | Nicotine addiction_Homo sapiens_hsa05033 | 1.06352689 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.05408857 |
| 56 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.04886933 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01086246 |
| 58 | Cocaine addiction_Homo sapiens_hsa05030 | 0.98740308 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98416060 |
| 60 | Tight junction_Homo sapiens_hsa04530 | 0.96395822 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94987835 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93330606 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92660903 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 0.92649527 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92049652 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89550838 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88731045 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.88538600 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87267209 |
| 70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87182934 |
| 71 | Bladder cancer_Homo sapiens_hsa05219 | 0.87085270 |
| 72 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.84951148 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84563533 |
| 74 | Long-term depression_Homo sapiens_hsa04730 | 0.81276106 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79696844 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78507014 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.76374820 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75713302 |
| 79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.74357850 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73764088 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73630642 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72903403 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71885194 |
| 84 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.71283669 |
| 85 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.71220628 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.70474674 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.69314976 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69233253 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66301959 |
| 90 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66292474 |
| 91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66012049 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65447790 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65410572 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.64195055 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.63710545 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63669959 |
| 97 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.63629964 |
| 98 | Taste transduction_Homo sapiens_hsa04742 | 0.61732137 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59698932 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.59224257 |
| 101 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58853461 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57423275 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.56938044 |
| 104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55710852 |
| 105 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54610276 |
| 106 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.54098857 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53632967 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53044307 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52501007 |
| 110 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51794905 |
| 111 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51767742 |
| 112 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51487413 |
| 113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51398025 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51018451 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50721839 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49628502 |
| 117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48304664 |
| 118 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47905423 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47153784 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46176078 |
| 121 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.43687991 |
| 122 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43639558 |
| 123 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42437372 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40438780 |
| 125 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.39435510 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36819882 |
| 127 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34048372 |

